Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease

Hayoung Choi, Byung Woo Jhun, Su Young Kim, Dae Hun Kim, Hyun Lee, Kyeongman Jeon, O. Jung Kwon, Hee Jae Huh, Chang Seok Ki, Nam Yong Lee, Sung Jae Shin, Charles L. Daley, Won Jung Koh

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Mycobacterium abscessus lung disease is difficult to treat due to inducible resistance to macrolides. However, 15%–20% of isolates are macrolide susceptible. In 14 patients with macrolide-susceptible M. abscessus lung disease, all isolates had nonfunctional erm(41) gene, and sputum culture conversion rate was achieved in 93% (13/14) following antibiotic therapy.

Original languageEnglish
Pages (from-to)293-295
Number of pages3
JournalDiagnostic Microbiology and Infectious Disease
Volume90
Issue number4
DOIs
Publication statusPublished - 2018 Apr

Fingerprint

Macrolides
Mycobacterium
Lung Diseases
Sputum
Anti-Bacterial Agents
Genes
Therapeutics

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Choi, Hayoung ; Jhun, Byung Woo ; Kim, Su Young ; Kim, Dae Hun ; Lee, Hyun ; Jeon, Kyeongman ; Kwon, O. Jung ; Huh, Hee Jae ; Ki, Chang Seok ; Lee, Nam Yong ; Shin, Sung Jae ; Daley, Charles L. ; Koh, Won Jung. / Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease. In: Diagnostic Microbiology and Infectious Disease. 2018 ; Vol. 90, No. 4. pp. 293-295.
@article{54ba7f46a182463bb7a093593226ffe3,
title = "Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease",
abstract = "Mycobacterium abscessus lung disease is difficult to treat due to inducible resistance to macrolides. However, 15{\%}–20{\%} of isolates are macrolide susceptible. In 14 patients with macrolide-susceptible M. abscessus lung disease, all isolates had nonfunctional erm(41) gene, and sputum culture conversion rate was achieved in 93{\%} (13/14) following antibiotic therapy.",
author = "Hayoung Choi and Jhun, {Byung Woo} and Kim, {Su Young} and Kim, {Dae Hun} and Hyun Lee and Kyeongman Jeon and Kwon, {O. Jung} and Huh, {Hee Jae} and Ki, {Chang Seok} and Lee, {Nam Yong} and Shin, {Sung Jae} and Daley, {Charles L.} and Koh, {Won Jung}",
year = "2018",
month = "4",
doi = "10.1016/j.diagmicrobio.2017.12.008",
language = "English",
volume = "90",
pages = "293--295",
journal = "Diagnostic Microbiology and Infectious Disease",
issn = "0732-8893",
publisher = "Elsevier Inc.",
number = "4",

}

Choi, H, Jhun, BW, Kim, SY, Kim, DH, Lee, H, Jeon, K, Kwon, OJ, Huh, HJ, Ki, CS, Lee, NY, Shin, SJ, Daley, CL & Koh, WJ 2018, 'Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease', Diagnostic Microbiology and Infectious Disease, vol. 90, no. 4, pp. 293-295. https://doi.org/10.1016/j.diagmicrobio.2017.12.008

Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease. / Choi, Hayoung; Jhun, Byung Woo; Kim, Su Young; Kim, Dae Hun; Lee, Hyun; Jeon, Kyeongman; Kwon, O. Jung; Huh, Hee Jae; Ki, Chang Seok; Lee, Nam Yong; Shin, Sung Jae; Daley, Charles L.; Koh, Won Jung.

In: Diagnostic Microbiology and Infectious Disease, Vol. 90, No. 4, 04.2018, p. 293-295.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease

AU - Choi, Hayoung

AU - Jhun, Byung Woo

AU - Kim, Su Young

AU - Kim, Dae Hun

AU - Lee, Hyun

AU - Jeon, Kyeongman

AU - Kwon, O. Jung

AU - Huh, Hee Jae

AU - Ki, Chang Seok

AU - Lee, Nam Yong

AU - Shin, Sung Jae

AU - Daley, Charles L.

AU - Koh, Won Jung

PY - 2018/4

Y1 - 2018/4

N2 - Mycobacterium abscessus lung disease is difficult to treat due to inducible resistance to macrolides. However, 15%–20% of isolates are macrolide susceptible. In 14 patients with macrolide-susceptible M. abscessus lung disease, all isolates had nonfunctional erm(41) gene, and sputum culture conversion rate was achieved in 93% (13/14) following antibiotic therapy.

AB - Mycobacterium abscessus lung disease is difficult to treat due to inducible resistance to macrolides. However, 15%–20% of isolates are macrolide susceptible. In 14 patients with macrolide-susceptible M. abscessus lung disease, all isolates had nonfunctional erm(41) gene, and sputum culture conversion rate was achieved in 93% (13/14) following antibiotic therapy.

UR - http://www.scopus.com/inward/record.url?scp=85040340954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040340954&partnerID=8YFLogxK

U2 - 10.1016/j.diagmicrobio.2017.12.008

DO - 10.1016/j.diagmicrobio.2017.12.008

M3 - Article

C2 - 29329759

AN - SCOPUS:85040340954

VL - 90

SP - 293

EP - 295

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

SN - 0732-8893

IS - 4

ER -